section 8
on 21 Oct 2022
Last Applicant/ Owned by
Suite 400
Bethesda
MD
20814
Serial Number
86977316 filed on 02th Jun 2014
Registration Number
4934252 registered on 05th Apr 2016
Correspondent Address
Joseph W. Berenato, III
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Providing comparative analysis of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings comparing abuse-deterrent features of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features with comparator products and similar prototype abuse-deterrent formulations; providing analysis in the field of pharmaceuticals, namely, preparation Read More
Providing comparative analysis of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings comparing abuse-deterrent features of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features with comparator products and similar prototype abuse-deterrent formulations; providing analysis in the field of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings with regard to the labor, effort and resources required to alter and or tamper with abuse-deterrent formulations and or new chemical entities with abuse-deterrent features; providing analysis in the field of pharmaceuticals, namely, preparation of reports, statistical analysis, studies and ratings with regard to the labor, effort and resources required to alter by means of tampering abuse-deterrent formulations and or new chemical entities with abuse-deterrent features
23rd Jun 2015
23rd Jun 2015
Consulting services in the field of pharmaceuticals, namely, quantitative assessment of drug tamperability and manipulation as it relates to abuse by various routes of drug administration; scientific and medical research and development related to pharmaceuticals formulated for abuse-deterrent applications and the abuse and diversion of pharmaceutical preparations; contract research services, namely, laboratory in vitro assessment as it relates to Food and Drug Administration Category 1 studies in the field of the alteration and tampering of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features; quality and safety management services, namely, evaluation and scientific analysis concerning the physical and chemical properties of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features; product development consultation, namely, assessment and analysis of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features as it relates to labor, effort and resources required to manipulate and alter abuse-deterrent formulations and or new chemical entities with abuse-deterrent features
23rd Jun 2015
23rd Jun 2015
Regulatory compliance consulting services in the field of abuse-deterrent formulations and or new chemical entities with abuse-deterrent features to ensure compliance with government standards concerning labeling, advertising and marketing, risk management and strategic communications, namely, translation of information to regulatory agencies
23rd Jun 2015
23rd Jun 2015
No 86977316
No Service Mark
No 6296.390
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
21st Oct 2022 | CANCELLED SEC. 8 (6-YR) |
05th Apr 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
05th Apr 2016 | REGISTERED-PRINCIPAL REGISTER |
02th Mar 2016 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
01st Mar 2016 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
24th Feb 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
24th Feb 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
17th Feb 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
01st Oct 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
01st Oct 2015 | NON-FINAL ACTION E-MAILED |